pamidronate has been researched along with Albers-Schoenberg Disease in 8 studies
Excerpt | Relevance | Reference |
---|---|---|
"Sixty-two (52." | 1.33 | Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. ( Broumand, V; Fortin, M; Marx, RE; Sawatari, Y, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wehrhan, F | 1 |
Hyckel, P | 1 |
Amann, K | 1 |
Ries, J | 1 |
Stockmann, P | 1 |
Schlegel, K | 1 |
Neukam, F | 1 |
Nkenke, E | 1 |
Whyte, MP | 1 |
Wenkert, D | 1 |
Clements, KL | 1 |
McAlister, WH | 1 |
Mumm, S | 1 |
Glorieux, FH | 1 |
Rauch, F | 1 |
Shapiro, JR | 1 |
Bjarnason, NH | 1 |
Tanvetyanon, T | 1 |
Ward, K | 1 |
Cowell, CT | 1 |
Little, DG | 1 |
Marx, RE | 1 |
Sawatari, Y | 1 |
Fortin, M | 1 |
Broumand, V | 1 |
Rawlinson, PS | 1 |
Green, RH | 1 |
Coggins, AM | 1 |
Boyle, IT | 1 |
Gibson, BE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 other studies available for pamidronate and Albers-Schoenberg Disease
Article | Year |
---|---|
Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
Topics: Alkaline Phosphatase; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Morphogen | 2011 |
Bisphosphonate-induced osteopetrosis.
Topics: Alkaline Phosphatase; Bone Density; Bone Marrow; Calcium; Child; Diphosphonates; Humans; Male; Osteo | 2003 |
Bisphosphonates in children with bone diseases.
Topics: Animals; Bone Density; Child; Diphosphonates; Humans; Knee Joint; Male; Osteogenesis Imperfecta; Ost | 2003 |
Bisphosphonates in children with bone diseases.
Topics: Bone Density; Bone Resorption; Child; Diphosphonates; Drug Administration Schedule; Humans; Ibandron | 2003 |
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazol | 2005 |
Quantification of metaphyseal modeling in children treated with bisphosphonates.
Topics: Adolescent; Bone Development; Bone Diseases; Child; Child, Preschool; Diphosphonates; Female; Femur; | 2005 |
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Topics: Abscess; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breas | 2005 |
Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Calcitonin; Child, Preschool; Diphosphonates; Female; Humans; Hypercalc | 1991 |